CHICAGO – The designated discussant for the PIONEER-HF presentation points out the importance of the results.
The agency found the lowest bleeding risk with apixaban, but cites lack of head-to-head trials as a limitation in evaluating DOACs.
Lower blood glucose targets in critically ill cardiac patients are associated with lower 30-day mortality, compared with higher targets.
Does B-type natriuretic peptide (BNP) have prognostic value outside of heart failure (HF) patients?
BOSTON – Missed doses of enoxaparin correlate with increased incidence of deep vein thrombosis.
SAN DIEGO – The study marks the first analysis of its kind in the United States.
ATLANTA – The prolonged period of heightened risk was evident in patients with both STEMI and NSTEMI.
A centralized monitoring system might help reduce unimportant alarms with no increase in cardiopulmonary arrest events.
ATLANTA – Study adds to the stroke literature on nationwide estimates of 30-day readmissions.